Login

FREE TRIAL  Receive 30 days of no-obligation access. SIGN UP

Home

Privacy News

OCR Issues Final Reproductive Privacy Rule, Eyes New Privacy Bill

The Biden administration on Monday (April 22) issued a final rule through HHS’ Office of Civil Rights that will strengthen the Health Insurance Portability and Accountability Act (HIPPA) to prohibit disclosing to law enforcement private health information related to reproductive health care for people who travel across state lines for abortion care.

House Passes Bill Aiming To Protect Health Data From Foreign Adversaries

Lawmakers Tell Hospitals To Protect LGBTQ Patient Information

Rules Watch

Harris Announces Beefed-Up, 3.48 HPRD Final SNF Staffing Rule

Vice President Kamala Harris on Monday morning (April 22) announced CMS’ nursing home final staffing minimums and a sweeping long-term care worker rule stemming from the Biden administration’s April 2023 executive order on the direct care workforce.

Harris Touts Medicaid-HCBS Access Rule Amid Slew Of New Health Policies

SNF Workforce Staffing Rule Clears OMB As Lawmakers Push To Block It

Latest News

Controversial Final FDA LDT Rule Cleared By White House

The White House’s Office of Information and Regulatory Affairs (OIRA) has signed off on FDA’s final rule for regulation of laboratory-developed tests (LDTs), indicating that the controversial, much-anticipated rule could be available at any time.

White House To Release Suicide Prevention Strategy Including 200 Federal Steps

The White House is releasing a new National Strategy for Suicide Prevention, updating the federal approach to the issue for the first time in more than a decade and launching a federal action plan with more 200 steps that the Biden administration hopes to take over the next three years, emphasizing priorities like health equity.

PBMs Highlight Rural Partnerships Amid Continued Calls For Reform

While the leading lobbying group for pharmacy benefit managers (PBMs) highlights the role of PBMs in rural pharmacy access, pharmacists’ groups remain steadfast in urging Congress to pass comprehensive legislation that would prohibit PBMs from engaging in business practices they say lead to higher prescription drug costs for patients and payers and pose a threat to the sustainability and operations of independent community pharmacies.